Woo Sung Shin

Title: Woo Sung Shin: Innovator in Vaccine Development

Introduction

Woo Sung Shin is a prominent inventor based in Gangwon, South Korea. He has made significant contributions to the field of vaccine development, particularly in the prevention of swine infections. His innovative work has the potential to enhance animal health and improve agricultural practices.

Latest Patents

Woo Sung Shin holds a patent for a vaccine composition comprising recombinant protein for preventing swine infection. This patent describes a recombinant protein that is used to produce a vaccine composition aimed at preventing swine infections. The vaccine composition, which includes the recombinant protein, has been shown to increase the immune response to both the swine infection and the P97 protein. As a result, this vaccine exhibits a defensive effect that surpasses existing commercially available vaccines. The recombinant proteins and the vaccine compositions derived from them are particularly effective in preventing diseases caused by swine-derived pneumonia and swine-derived arthritis.

Career Highlights

Woo Sung Shin is associated with Innovac, a company dedicated to advancing veterinary health solutions. His work at Innovac has focused on developing innovative vaccine technologies that address critical health issues in swine populations. His contributions have been instrumental in enhancing the effectiveness of vaccines in the agricultural sector.

Collaborations

Some of Woo Sung Shin's notable coworkers include Tae Wook Hahn and Kashinath Abhijit Barate. Their collaborative efforts contribute to the ongoing research and development initiatives at Innovac.

Conclusion

Woo Sung Shin's innovative work in vaccine development represents a significant advancement in the prevention of swine infections. His contributions have the potential to improve animal health and agricultural practices, making a lasting impact in the field.